Minolira Extended Release
Product Images NDC 71403-102

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Minolira Extended Release (NDC 71403-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epi Health, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Minolira 01)

Chemical structure of the active ingredient of Minolira Extended Release by EPI Health, Inc. The diagram shows the molecular structure including ring systems, functional groups such as hydroxyl (OH), carbonyl (C=O), amide (CONH2), and hydrochloride (HCl) indicated as a separate entity.*

FDA Label Image

Image (Minolira 02)

Minolira Extended Release tablet with imprint 'M 1', shown as a white, rectangular, biconvex tablet scored to allow splitting. Labeler is EPI Health, Inc.*

FDA Label Image

Image (Minolira 03)

The image shows a black and white line drawing of a blister pack with 6 oval-shaped tablets arranged in two rows of three. This blister packaging is typical for oral extended-release tablets, likely corresponding to Minolira Extended Release by EPI Health, Inc.*

FDA Label Image

Image (Minolira 04)

An instructional line drawing showing a person's hands holding a tablet by its edges, demonstrating how to split or break the Minolira Extended Release tablet properly.*

FDA Label Image

Image (Minolira 05)

An instructional diagram showing two hands holding and breaking a tablet in half, illustrating how to split the Minolira Extended Release tablet.*

FDA Label Image

Image (Minolira 06)

Minolira Extended Release tablet with distinct imprint 'M' on one side and '1' on the other. The image shows the shape and imprint of the tablet from both sides. No additional packaging or labeling details are visible. Labeler is EPI Health, Inc as per product data.*

FDA Label Image

Image (Minolira 07)

An instructional line drawing showing a hand holding a single capsule tablet between the thumb and forefinger, demonstrating how to hold the capsule for administration.*

FDA Label Image

Image (Minolira 08)

Minolira Extended Release tablet scored into two parts, marked with 'M' on the left side and '3' on the right side, indicating dosage identification. The labeler is EPI Health, Inc.*

FDA Label Image

Image (Minolira 09)

Chemical structure diagram of the active ingredient in Minolira Extended Release as shown in the image. The diagram depicts the molecular bonds and atoms in a two-dimensional format typical of pharmaceutical structural formulas.*

FDA Label Image

Image (Minolira 10)

An illustration showing a pair of hands holding and bending a Minolira Extended Release tablet in half. The diagram demonstrates the tablet's breakability or to illustrate how to split the tablet if necessary.*

FDA Label Image

Image (Minolira 11)

An instructional line drawing depicting two hands holding a capsule, demonstrating how to open or split the capsule. The image is related to Minolira Extended Release by EPI Health, Inc, suggesting how to handle the extended release capsule form safely.*

FDA Label Image

Image (Minolira 12)

Minolira Extended Release tablet displaying imprint side. One side shows a capital letter 'M' within a square border, the other side shows the number '3' within a square border. No additional text or graphics are visible. Labeler is EPI Health, Inc.*

FDA Label Image

Image (Minolira 13)

An instructional illustration showing a hand holding a single oblong pill between the thumb and index finger, likely demonstrating how to handle or administer the medication Minolira Extended Release.*

FDA Label Image

Principal Display Panel (135 mg Tablet Bottle Label)

Label for Minolira extended-release tablets containing 135 mg of minocycline hydrochloride. The label includes dosage storage instructions, manufacturer Dr. Reddy's Laboratories Limited in India, and the labeler EPI Health, Inc in Charleston, SC. The package contains 30 tablets.*

FDA Label Image

Principal Display Panel (105 mg Tablet Bottle Label)

Minolira extended-release tablets with 105 mg minocycline hydrochloride per tablet. The label includes dosage instructions to see package insert, storage conditions, and child-resistant closure information. The product contains 30 tablets and is manufactured for EPI Health, LLC by Dr. Reddy's Laboratories in India. The label displays the NDC 71403-101-30 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.